Englander Institute for Precision Medicine
Found 877 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2023
Fornarini G, Rebuzzi SE, Buti S, Rescigno P, Merseburger A, Sternberg CN, De Giorgi U, Basso U, Maruzzo M, Giannatempo P et al..  2023.  A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.. Minerva Urol Nephrol. 75(3):308-318.
Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJun, Choi MHo, Sun Q, Savenkov O, Louka C, Liu C et al..  2023.  Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in .. Sci Transl Med. 15(684):eade1857.
Lauritsen J, Sauvé N, Tryakin A, Jiang DMaria, Huddart R, Heng DYC, Terbuch A, Winquist E, Chovanec M, Hentrich M et al..  2023.  Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.. Br J Cancer. 129(11):1759-1765.
Vanpouille-Box C, Galluzzi L.  2023.  p53 regulates the mitochondrial immune checkpoint.. Trends Immunol. 44(4):245-247.
Li Y, Porta-Pardo E, Tokheim C, Bailey MH, Yaron TM, Stathias V, Geffen Y, Imbach KJ, Cao S, Anand S et al..  2023.  Pan-cancer proteogenomics connects oncogenic drivers to functional states.. Cell. 186(18):3921-3944.e25.
Rowdo FPMadorsky, Xiao G, Khramtsova GF, Nguyen J, Olopade OI, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK et al..  2023.  Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.. bioRxiv.
Askari E, Moghadam SZarehparva, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CMaria, Walter MAlexander et al..  2023.  Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.. J Nucl Med Technol. 51(1):22-25.
Borregales LD, Venkat S, Calderon LPosada, Lewicki P, Flynn T, Faltas BM, Molina AM, Golombos DM, O'Malley P, Scherr DS.  2023.  A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer.. Eur Urol. 84(6):604-606.
Hussain M, Sternberg CN, Efstathiou E, Fizazi K, Shen Q, Lin X, Sugg J, Steinberg J, Noerby B, De Giorgi U et al..  2023.  Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide? Future Oncol. 19(29):1953-1960.
Benedetti E, Chetnik K, Flynn T, Barbieri CE, Scherr DS, Loda M, Krumsiek J.  2023.  Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort.. Sci Data. 10(1):830.
Kandola MS, Kulm S, Kim LK, Markowitz SM, Liu CF, Thomas G, Ip JE, Lerman BB, Elemento O, Cheung JW.  2023.  Population-Level Prevalence of Rare Variants Associated With Atrial Fibrillation and its Impact on Patient Outcomes.. JACC Clin Electrophysiol.
Charilaou P, Mohapatra S, Doukas S, Kohli M, Radadiya D, Devani K, Broder A, Elemento O, Lukin DJ, Battat R.  2023.  Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.. J Gastroenterol Hepatol. 38(2):241-250.
Stangl-Kremser J, Sun M, Ho B, Thomas J, Nauseef JT, Osborne JR, Molina A, Sternberg CN, Nanus DM, Bander NH et al..  2023.  Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.. Prostate. 83(14):1351-1357.
Parent P, Auclin E, Patrikidou A, Mezquita L, Chanzá NMartínez, Dumont C, Rodriguez-Vida A, Llacer C, Lozano R, Ratta R et al..  2023.  Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.. Cancers (Basel). 15(4)
Guilbaud E, Spada S, Bloy N, Galassi C, Sato A, Jiménez-Cortegana C, Aretz A, Buqué A, Yamazaki T, Demaria S et al..  2023.  Quantitative assessment of mitophagy in irradiated cancer cells.. Methods Cell Biol. 174:93-111.
Sato A, Kraynak J, Marciscano AE, Galluzzi L.  2023.  Radiation therapy: An old dog learning new tricks.. Methods Cell Biol. 180:xv-xxv.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche J-B, Golden E, Boyer O, Van Besien K, Formenti SC, Galluzzi L et al..  2023.  Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.. Cell Death Dis. 14(5):305.
Pouget J-P, Chan TA, Galluzzi L, Constanzo J.  2023.  Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors.. Trends Cancer. 9(11):968-981.
Marciscano AE, Wolfe S, Zhou XKathy, Barbieri CE, Formenti SC, Hu JC, Molina AM, Nanus DM, Nauseef JT, Scherr DS et al..  2023.  Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).. BMC Cancer. 23(1):781.
Jbara A, Lin K-T, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, Elyada E, Mogilevsky M, Raitses-Gurevich M, Johnson JL et al..  2023.  RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.. Nature. 617(7959):147-153.
Xu D, Forbes ANeil, Cohen S, Palladino A, Karadimitriou T, Khurana E.  2023.  Recapitulation of patient-specific 3D chromatin conformation using machine learning.. Cell Rep Methods. 3(9):100578.
Falvo DJ, Grimont A, Zumbo P, Fall WB, Yang JL, Osterhoudt A, Pan G, Rendeiro AF, Meng Y, Wilkinson JE et al..  2023.  A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas.. Dev Cell. 58(24):2959-2973.e7.
Matsubara N, de Bono J, Sweeney C, Chi KN, Olmos D, Sandhu S, Massard C, Garcia J, Chen G, Harris A et al..  2023.  Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer.. Clin Genitourin Cancer. 21(2):230-237.e1.
Higgins CA, Nilsson-Payant BE, Bonaventure B, Kurland AP, Ye C, Yaron TM, Johnson JL, Adhikary P, Golynker I, Panis M et al..  2023.  SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.. mBio. :e0100723.
Chin AF, Han J, Clement CC, Choi Y, Zhang H, Browne M, Jeon OHee, Elisseeff JH.  2023.  Senolytic treatment reduces oxidative protein stress in an aging male murine model of post-traumatic osteoarthritis.. Aging Cell. 22(11):e13979.